184 related articles for article (PubMed ID: 36056210)
21. [Ikaros Family Zinc Finger 1 Mutation Is an Adverse Prognostic Factor for Patients with Adult B-Cell Acute Lymphoblastic Leukemia].
Tang SH; Lu Y; Zhang PS; Liu XH; DU XH; Chen D; Pei RZ; Tang XW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):405-410. PubMed ID: 32319370
[TBL] [Abstract][Full Text] [Related]
22. Clinical impacts of copy number variations in B-cell differentiation and cell cycle control genes in pediatric B-cell acute lymphoblastic leukemia: a single centre experience.
Crepinsek K; Marinsek G; Kavcic M; Prelog T; Kitanovski L; Jazbec J; Debeljak M
Radiol Oncol; 2021 Dec; 56(1):92-101. PubMed ID: 34957727
[TBL] [Abstract][Full Text] [Related]
23. CD20 positivity and white blood cell count predict treatment outcomes in Philadelphia chromosome-negative acute lymphoblastic leukemia patients ineligible for pediatric-inspired chemotherapy.
Isshiki Y; Ohwada C; Sakaida E; Onoda M; Aotsuka N; Tanaka H; Fukazawa M; Cho R; Sugawara T; Kawaguchi T; Hara S; Yokota A
Jpn J Clin Oncol; 2017 Nov; 47(11):1047-1054. PubMed ID: 28973362
[TBL] [Abstract][Full Text] [Related]
24. IKZF1 deletions predict a poor prognosis in children with B-cell progenitor acute lymphoblastic leukemia: a multicenter analysis in Taiwan.
Yang YL; Hung CC; Chen JS; Lin KH; Jou ST; Hsiao CC; Sheen JM; Cheng CN; Wu KH; Lin SR; Yu SL; Chen HY; Lu MY; Wang SC; Chang HH; Lin SW; Su YN; Lin DT
Cancer Sci; 2011 Oct; 102(10):1874-81. PubMed ID: 21740479
[TBL] [Abstract][Full Text] [Related]
25. Refining risk stratification in paediatric B-acute lymphoblastic leukaemia: Combining IKZF1
Liu HC; Huang YJ; Jaing TH; Wu KH; Chen SH; Wang SC; Yeh TC; Hsiao CC; Chang TK; Yen HJ; Huang FL; Lin PC; Hou JY; Sheen JM; Liao YM; Chang TY; Chen YC; Chiou SS; Yang CP; Pui CH; Liang DC; Shih LY
Br J Haematol; 2024 Apr; 204(4):1344-1353. PubMed ID: 38479427
[TBL] [Abstract][Full Text] [Related]
26. Intensifying Treatment of Childhood B-Lymphoblastic Leukemia With IKZF1 Deletion Reduces Relapse and Improves Overall Survival: Results of Malaysia-Singapore ALL 2010 Study.
Yeoh AEJ; Lu Y; Chin WHN; Chiew EKH; Lim EH; Li Z; Kham SKY; Chan YH; Abdullah WA; Lin HP; Chan LL; Lam JCM; Tan PL; Quah TC; Tan AM; Ariffin H
J Clin Oncol; 2018 Sep; 36(26):2726-2735. PubMed ID: 30044693
[TBL] [Abstract][Full Text] [Related]
27. High frequency of IKZF1 genetic alterations in adult patients with B-cell acute lymphoblastic leukemia.
Tokunaga K; Yamaguchi S; Iwanaga E; Nanri T; Shimomura T; Suzushima H; Mitsuya H; Asou N
Eur J Haematol; 2013 Sep; 91(3):201-208. PubMed ID: 23751147
[TBL] [Abstract][Full Text] [Related]
28. IKZF1
Ito Y; Ozawa H; Eto T; Miyamoto T; Kamimura T; Ogawa R; Uchida N; Wake A; Fujisaki T; Ohno Y; Takase K; Okumura H; Takamatsu Y; Kawano N; Akashi K; Nagafuji K
Eur J Haematol; 2023 Jul; 111(1):103-112. PubMed ID: 36991564
[TBL] [Abstract][Full Text] [Related]
29. Allogeneic HCT for adults with B-cell precursor acute lymphoblastic leukemia harboring IKZF1 gene mutations. A study by the Acute Leukemia Working Party of the EBMT.
Giebel S; Labopin M; Socié G; Beauvais D; Klein S; Wagner-Drouet EM; Blaise D; Nguyen-Quoc S; Bourhis JH; Thiebaut A; Labussière-Wallet H; Charbonnier A; Berceanu A; Diez-Martin JL; Fegueux N; Esteve J; Nagler A; Mohty M
Bone Marrow Transplant; 2021 May; 56(5):1047-1055. PubMed ID: 33235351
[TBL] [Abstract][Full Text] [Related]
30. The prognostic impact of IKZF1 deletions and UKALL genetic classifiers in paediatric B-cell precursor acute lymphoblastic leukaemia treated according to NOPHO 2008 protocols.
Öfverholm I; Rezayee F; Heyman M; Harila A; Arvidsson L; Schmiegelow K; Norén-Nyström U; Barbany G
Br J Haematol; 2023 Jul; 202(2):384-392. PubMed ID: 37156607
[TBL] [Abstract][Full Text] [Related]
31. [The value of minimal residual disease and IKZF1 deletion for predicting prognosis in adult patients with B-cell acute lymphoblastic leukemia].
Deng SY; Ou JW; Huang ZC; Chen JJ; Cai ZH; Liu QF; Zhou HS
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):257-263. PubMed ID: 38716597
[No Abstract] [Full Text] [Related]
32. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.
Mullighan CG; Su X; Zhang J; Radtke I; Phillips LA; Miller CB; Ma J; Liu W; Cheng C; Schulman BA; Harvey RC; Chen IM; Clifford RJ; Carroll WL; Reaman G; Bowman WP; Devidas M; Gerhard DS; Yang W; Relling MV; Shurtleff SA; Campana D; Borowitz MJ; Pui CH; Smith M; Hunger SP; Willman CL; Downing JR;
N Engl J Med; 2009 Jan; 360(5):470-80. PubMed ID: 19129520
[TBL] [Abstract][Full Text] [Related]
33. Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.
Volejnikova J; Mejstrikova E; Dörge P; Meissner B; Zimmermannova O; Svojgr K; Stanulla M; Cario G; Schrappe M; Stary J; Hrusak O; Trka J; Fronkova E
Pediatr Blood Cancer; 2013 Mar; 60(3):420-7. PubMed ID: 22997141
[TBL] [Abstract][Full Text] [Related]
34. The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013.
Olsson L; Ivanov Öfverholm I; Norén-Nyström U; Zachariadis V; Nordlund J; Sjögren H; Golovleva I; Nordgren A; Paulsson K; Heyman M; Barbany G; Johansson B
Br J Haematol; 2015 Sep; 170(6):847-58. PubMed ID: 26018335
[TBL] [Abstract][Full Text] [Related]
35. What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia?
Palmi C; Valsecchi MG; Longinotti G; Silvestri D; Carrino V; Conter V; Basso G; Biondi A; Kronnie GT; Cazzaniga G
Haematologica; 2013 Aug; 98(8):1226-31. PubMed ID: 23585525
[TBL] [Abstract][Full Text] [Related]
36. IKAROS Gene Deleted B-Cell Acute Lymphoblastic Leukemia in Mexican Mestizos: Observations in Seven Patients and a Short Review of the Literature.
Ruiz-Delgado GJ; Cantero-Fortiz Y; León-Peña AA; León-González M; Nuñez-Cortés AK; Ruiz-Argüelles GJ
Rev Invest Clin; 2016; 68(4):210-4. PubMed ID: 27623040
[TBL] [Abstract][Full Text] [Related]
37. The impact of IKZF1 deletion on the prognosis of acute lymphoblastic leukemia: an updated meta-analysis.
Jia M; Wang ZJ; Li JY; Yang SL; Zhao HZ; Cheng YP; Luo ZB; Tang YM
Cancer Biomark; 2014; 14(6):493-503. PubMed ID: 25335741
[TBL] [Abstract][Full Text] [Related]
38. Aberrant IKZF1 gene as relapse predictor in standard-risk pediatric patients with B-cell precursor acute lymphoblastic leukaemia.
Vshyukova VS; Krasko OV; Yanchanka DA; Meleshko AN
Int J Lab Hematol; 2022 Aug; 44(4):769-776. PubMed ID: 35505470
[TBL] [Abstract][Full Text] [Related]
39. Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance.
Vitanza NA; Zaky W; Blum R; Meyer JA; Wang J; Bhatla T; Morrison DJ; Raetz EA; Carroll WL
Pediatr Blood Cancer; 2014 Oct; 61(10):1779-85. PubMed ID: 24976218
[TBL] [Abstract][Full Text] [Related]
40. [Ikaros family zinc finger 1 mutation is a poor prognostic factor for adult Philadelphia chromosome positive acute lymphoblastic leukemia].
Tang SH; Lu Y; Zhang PS; Liu XH; Du XH; Chen D; Li SY; Cao JJ; Chen LG; Le J; Qian SY; Hong YW; Pei RZ
Zhonghua Nei Ke Za Zhi; 2019 Apr; 58(4):301-306. PubMed ID: 30917424
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]